Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Clara Vazeille

Showing results (1-10 of 4) with videos related to

Pageof 1
Sort By:
Current Opinion in Clinical Nutrition and Metabolic Care|January 26, 2018
Resting energy metabolism and anticancer treatmentsAnne Jouinot, Clara Vazeille, François Goldwasser
The American Journal of Clinical Nutrition|March 31, 2017
Relation between hypermetabolism, cachexia, and survival in cancer patients: a prospective study in 390 cancer patients before initiation of anticancer therapyClara Vazeille, Anne Jouinot, Jean-Philippe Durand, et al.
Clinical Nutrition (Edinburgh, Scotland)|February 2, 2017
Resting energy expenditure in the risk assessment of anticancer treatmentsAnne Jouinot, Clara Vazeille, Jean Philippe Durand, et al.
Clinical Nutrition (Edinburgh, Scotland)|August 25, 2019
Hypermetabolism is an independent prognostic factor of survival in metastatic non-small cell lung cancer patientsAnne Jouinot, Guillaume Ulmann, Clara Vazeille, et al.
Pageof 1

Showing results (1-10 of 4) with videos related to

Sort By:
Pageof 1
Current Opinion in Clinical Nutrition and Metabolic Care|January 26, 2018
Resting energy metabolism and anticancer treatmentsAnne Jouinot, Clara Vazeille, François Goldwasser
The American Journal of Clinical Nutrition|March 31, 2017
Relation between hypermetabolism, cachexia, and survival in cancer patients: a prospective study in 390 cancer patients before initiation of anticancer therapyClara Vazeille, Anne Jouinot, Jean-Philippe Durand, et al.
Clinical Nutrition (Edinburgh, Scotland)|February 2, 2017
Resting energy expenditure in the risk assessment of anticancer treatmentsAnne Jouinot, Clara Vazeille, Jean Philippe Durand, et al.
Clinical Nutrition (Edinburgh, Scotland)|August 25, 2019
Hypermetabolism is an independent prognostic factor of survival in metastatic non-small cell lung cancer patientsAnne Jouinot, Guillaume Ulmann, Clara Vazeille, et al.
Pageof 1